✨ Your Portfolio is fetched and updated from zerodha.
Small Hospitals

Thyrocare Technologies Ltd.

THYROCARE

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹6,250 Cr.
P/E
58.73

Thyrocare Technologies Ltd.

  • Thyrocare Tech.
  • Vimta Labs
  • Krsnaa Diagnostics
  • TJI Diagnostic Chains

FAQs on Thyrocare Technologies Ltd. Shareprice

Thyrocare Tech. has given better returns compared to its competitors.
Thyrocare Tech. has grown at ~19.35% over the last 3yrs while peers have grown at a median rate of 14.92%

Yes, Thyrocare Tech. is expensive.
Latest PE of Thyrocare Tech. is 58.73, while 3 year average PE is 43.48.
Also latest EV/EBITDA of Thyrocare Tech. is 30.15 while 3yr average is 24.79.

View FAQ's On Business

Growth Table

  • Thyrocare Technologies Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics

Balance Sheet

  • Thyrocare Technologies Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Thyrocare Technologies Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics

Cash Flow

  • Thyrocare Technologies Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Thyrocare Technologies Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics

Quarterly Results

  • Thyrocare Technologies Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Thyrocare Technologies Ltd. Financials

Balance sheet of Thyrocare Tech. is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Thyrocare Tech. is decreasing.
Latest net debt of Thyrocare Tech. is -₹108.8 Crs as of Mar-25.
This is less than Mar-24 when it was -₹58.07 Crs.

Yes, profit is increasing.
The profit of Thyrocare Tech. is ₹106 Crs for TTM, ₹90.74 Crs for Mar 2025 and ₹71.05 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Thyrocare Tech. latest dividend payout ratio is 122.63% and 3yr average dividend payout ratio is 128.39%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech